tiprankstipranks
Trending News
More News >
Mckesson Corp. (MCK)
NYSE:MCK
US Market
Advertisement

McKesson (MCK) Earnings Dates, Call Summary & Reports

Compare
2,116 Followers

Earnings Data

Report Date
Feb 04, 2026
Before Open (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
9.4
Last Year’s EPS
8.03
Same Quarter Last Year
Based on 15 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
McKesson reported strong financial performance with significant growth in revenue and earnings, driven by robust performance in oncology and multispecialty segments and prescription technology solutions. The company raised its earnings guidance, reflecting confidence in continued growth. However, challenges in the Medical-Surgical Solutions segment present some concerns. Overall, the strengths significantly outweigh the challenges.
Company Guidance
During McKesson's second quarter fiscal 2026 earnings call, the company reported strong financial performance, with consolidated revenues increasing by 10% year-over-year to $103 billion and adjusted earnings per diluted share rising by 39% to $9.86. Three of McKesson's segments achieved double-digit adjusted operating profit growth, showcasing the company's successful execution of strategic priorities. Based on this robust performance and a positive outlook for the year, McKesson raised its guidance for adjusted earnings per diluted share to a range of $38.35 to $38.85, building on a previous $0.80 increase announced in September. This upward revision underscores the company's confidence in its diversified portfolio and strategic initiatives, including the formation of new reporting structures like the oncology and multispecialty segment and the North American Pharmaceutical segment, aimed at optimizing portfolio management and driving long-term shareholder value.
Strong Revenue and Earnings Growth
Consolidated revenues increased 10% year-over-year to $103 billion, with adjusted earnings per diluted share increasing 39% to $9.86. Three segments delivered double-digit adjusted operating profit growth.
Oncology and Multispecialty Segment Success
Revenues increased 32% to $12 billion, driven by strong provider and specialty distribution growth, including acquisitions. Operating profit increased 71% to $397 million.
Prescription Technology Solutions Growth
Revenues increased 9% to $1.4 billion, with operating profit rising 20% to $261 million due to increased demand for access solutions and prior authorization services.
Increased Earnings Guidance
Guidance for adjusted earnings per diluted share raised to $38.35 - $38.85, representing 16% to 18% growth over the prior year.
Successful Implementation of New Reporting Structure
Introduction of new reporting structure enhances transparency and aligns with strategic growth areas, particularly in oncology and biopharma services.

McKesson (MCK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MCK Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 04, 2026
2026 (Q3)
9.40 / -
8.03
Nov 05, 2025
2026 (Q2)
9.03 / 9.86
7.0739.46% (+2.79)
Aug 06, 2025
2026 (Q1)
8.14 / 8.26
7.884.82% (+0.38)
May 08, 2025
2025 (Q4)
9.83 / 10.12
6.1863.75% (+3.94)
Feb 05, 2025
2025 (Q3)
7.99 / 8.03
7.743.75% (+0.29)
Nov 06, 2024
2025 (Q2)
6.88 / 7.07
6.2313.48% (+0.84)
Aug 07, 2024
2025 (Q1)
7.21 / 7.88
7.278.39% (+0.61)
May 07, 2024
2024 (Q4)
6.36 / 6.18
7.19-14.05% (-1.01)
Feb 07, 2024
2024 (Q3)
7.04 / 7.74
6.912.17% (+0.84)
Nov 01, 2023
2024 (Q2)
6.15 / 6.23
6.062.81% (+0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MCK Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$844.26$858.61+1.70%
Aug 06, 2025
$702.92$662.46-5.76%
May 08, 2025
$688.74$691.95+0.47%
Feb 05, 2025
$604.90$597.78-1.18%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Mckesson Corp. (MCK) report earnings?
Mckesson Corp. (MCK) is schdueled to report earning on Feb 04, 2026, Before Open (Confirmed).
    What is Mckesson Corp. (MCK) earnings time?
    Mckesson Corp. (MCK) earnings time is at Feb 04, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MCK EPS forecast?
          MCK EPS forecast for the fiscal quarter 2026 (Q3) is 9.4.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis